Multilineage Potential of Adult Human Mesenchymal Stem Cells
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Human mesenchymal stem cells are thought to be multipotent cells, which are present in adult marrow, that can replicate as undifferentiated cells and that have the potential to differentiate to lineages of mesenchymal tissues, including bone, cartilage, fat, tendon, muscle, and marrow stroma. Cells that have the characteristics of human mesenchymal stem cells were isolated from marrow aspirates of volunteer donors. These cells displayed a stable phenotype and remained as a monolayer in vitro. These adult stem cells could be induced to differentiate exclusively into the adipocytic, chondrocytic, or osteocytic lineages. Individual stem cells were identified that, when expanded to colonies, retained their multilineage potential.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Additionally, harvesting BM-MSCs is limited by the potential pain and morbidity associated with bone marrow aspiration, and only a small fraction (0.001–0.01%) of harvested bone marrow cells are MSCs [58,67].”
From Mesenchymal Stem/Stromal Cells: Immunomodulatory and Bone Regeneration Potential after Tumor Excision in Osteosarcoma Patients (2023) · cites this paper as [67]
Citations
Cites
Embryonic Stem Cell Lines Derived from Human Blastocysts
Thomson, J. A., Itskovitz-Eldor, J., Shapiro, S. S., Waknitz, M. A., Swiergiel, J. J., Marshall, V. S., & Jones, J. M. (1998) · Science · doi:10.1126/science.282.5391.1145 · Cited by 15,926
Caplan, A. I. (1991) · Journal of Orthopaedic Research · doi:10.1002/jor.1100090504 · Cited by 6,548
Marrow Stromal Cells as Stem Cells for Nonhematopoietic Tissues
Prockop, D. J. (1997) · Science · doi:10.1126/science.276.5309.71 · Cited by 4,629
A Direct Measurement of the Radiation Sensitivity of Normal Mouse Bone Marrow Cells1
Till, J. E., & McCulloch, E. A. (2011) · Radiation Research · doi:10.1667/rrxx28.1 · Cited by 4,036
A Direct Measurement of the Radiation Sensitivity of Normal Mouse Bone Marrow Cells
Till, J. E., & McCulloch, E. A. (1961) · Radiation Research · doi:10.2307/3570892 · Cited by 3,708
In VitroChondrogenesis of Bone Marrow-Derived Mesenchymal Progenitor Cells
Johnstone, B., Hering, T. M., Caplan, A. I., Goldberg, V. M., & Yoo, J. U. (1998) · Experimental Cell Research · doi:10.1006/excr.1997.3858 · Cited by 2,382
Mesenchymal cell-based repair of large, full-thickness defects of articular cartilage.
Wakitani, S., Goto, T., Pineda, S. J., Young, R. G., Mansour, J. M., Caplan, A. I., & Goldberg, V. M. (1994) · The Journal of Bone & Joint Surgery · doi:10.2106/00004623-199404000-00013 · Cited by 1,605
Bruder, S. P., Jaiswal, N., & Haynesworth, S. E. (1997) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(199702)64:2<278::aid-jcb11>3.0.co;2-f · Cited by 1,485
Derivation of pluripotent stem cells from cultured human primordial germ cells
Shamblott, M. J., Axelman, J., Wang, S., Bugg, E. M., Littlefield, J. W., Donovan, P. J., Blumenthal, P. D., Huggins, G. R., & Gearhart, J. D. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13726 · Cited by 1,420
Circulating Fibrocytes Define a New Leukocyte Subpopulation That Mediates Tissue Repair
Bucala, R., Spiegel, L. A., Chesney, J., Hogan, M., & Cerami, A. (1994) · Molecular Medicine · doi:10.1007/bf03403533 · Cited by 1,308
Research works printed but not linked: 4
- ; M. Owen and A. J. Friedenstein in Cell and Molecular Biology of Vertebrate Hard Tissues D. Evered and S. Harnett Eds. (Wiley Chichester UK 1988) pp. 42–60.
- Friedenstein A. J., Chailakhyan R. K., Gerasimov U. V., Cell Tissue Kinet. 20, 263 (1987);
- Bab I., Howlett C. R., Ashton B. A., Owen M. E., ibid. 187, 243 (1984).
- We thank D. Fink J. Andres R. Deans F. Barry S Bruder M. Thiede A. Moseley and J. Burns for discussion and review of the manuscript; M. Black and M. Earlington for cell isolation from marrow; and D. Sterchi D. Brown and J. Skwarek for histology. This work was supported by Osiris Therapeutics (www.osiristx.com) and in part by a research contract from the Defense Advanced Research Projects Agency.
Cited by
Items 1,401–1,500 of 1,649
Cho, H. H., Park, H. T., Kim, Y. J., Bae, Y. C., Suh, K. T., & Jung, J. S. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20544 · Cited by 178
“Mesenchymal stem cells (MSC), which can be isolated from bone marrow, adipose tissue, and cord blood, are defined as amultipotent cell with limited self-renewal capacity, and can be differentiated into adipocytes, chondrocytes, myoblasts, and osteoblasts [Caplan, 1991; Beresford et al., 1992; Pittenger et al., 1999; Z…”
BackgroundRegenerative and immunomodulatory potential of mesenchymal stem cells
KRAMPERA, M., PASINI, A., PIZZOLO, G., COSMI, L., ROMAGNANI, S., & ANNUNZIATO, F. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.02.008 · Cited by 177
Kang, J. W., Kang, K.-S., Koo, H. C., Park, J. R., Choi, E. W., & Park, Y. H. (2008) · Stem Cells and Development · doi:10.1089/scd.2007.0153 · Cited by 177
“MSCs can be isolated from bone marrow [1], adipose tissue [2], and umbilical cord blood [3] from many animals, including canine, equine, porcine, and feline species [4–7].”
Role of mesenchymal stem cells in regenerative medicine: application to bone and cartilage repair
Granero-Molto, F., Weis, J. A., Longobardi, L., & Spagnoli, A. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.3.255 · Cited by 176
“MSC are a heterogeneous population of multipotent cells that are frequently described as fibroblast-like colonies from bone marrow with the capacity to attach to plastic surfaces and to differentiate, under defined conditions, into osteoblasts, adipocytes and chondrocytes [68,69] .”
BackgroundInterleukin 6 mediated recruitment of mesenchymal stem cells to the hypoxic tumor milieu
Rattigan, Y., Hsu, J.-M., Mishra, P. J., Glod, J., & Banerjee, D. (2010) · Experimental Cell Research · doi:10.1016/j.yexcr.2010.07.002 · Cited by 176
Polycaprolactone electrospun mesh conjugated with an MSC affinity peptide for MSC homing in vivo
Shao, Z., Zhang, X., Pi, Y., Wang, X., Jia, Z., Zhu, J., Dai, L., Chen, W., Yin, L., Chen, H., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.01.033 · Cited by 176
Uncovering the secretes of mesenchymal stem cells
Lavoie, J. R., & Rosu-Myles, M. (2013) · Biochimie · doi:10.1016/j.biochi.2013.06.017 · Cited by 176
Shen, B., Wei, A., Whittaker, S., Williams, L. A., Tao, H., Ma, D. D. F., & Diwan, A. D. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22412 · Cited by 175
“Chondrogenic differentiation of BM MSCs can generally be induced by stimulation with all isoforms of TGF-b in serum-free medium at high cell density [Mackay et al., 1998; Pittenger et al., 1999].”
BackgroundMinardi, S., Corradetti, B., Taraballi, F., Sandri, M., Van Eps, J., Cabrera, F. J., Weiner, B. K., Tampieri, A., & Tasciotti, E. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.05.011 · Cited by 175
“Despite the cortical [44, 45] and trabecular [46-48] portions of the bone having been recently suggested as the major reserve of more potent osteoprogenitor cells, we chose to test this hypothesis using hBM-MSC, due to well-established isolation and expansion protocols [49-51], and the fact that they have been extensi…”
BackgroundKisiel, A. H., McDuffee, L. A., Masaoud, E., Bailey, T. R., Esparza Gonzalez, B. P., & Nino-Fong, R. (2012) · American Journal of Veterinary Research · doi:10.2460/ajvr.73.8.1305 · Cited by 175
Bone Morphogenetic Protein-Transduced Human Fibroblasts Convert to Osteoblasts and Form Bone in Vivo
Rutherford, R. B., Moalli, M., Franceschi, R. T., Wang, D., Gu, K., & Krebsbach, P. H. (2002) · Tissue Engineering · doi:10.1089/107632702760184709 · Cited by 174
Nanomaterials for Engineering Stem Cell Responses
Kerativitayanan, P., Carrow, J. K., & Gaharwar, A. K. (2015) · Advanced Healthcare Materials · doi:10.1002/adhm.201500272 · Cited by 174
Mesenchymal stem cell spheroids exhibit enhanced in-vitro and in-vivo osteoregenerative potential
Yamaguchi, Y., Ohno, J., Sato, A., Kido, H., & Fukushima, T. (2014) · BMC Biotechnology · doi:10.1186/s12896-014-0105-9 · Cited by 174
“Bone marrow contains hematopoietic stem cells, mesenchymal stem/stromal cells (MSCs), and multipotent adult progenitor cells [10-12].”
BackgroundZhang, H., Lin, C.-Y., & Hollister, S. J. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2009.04.015 · Cited by 174
“Bone marrow stromal cells (BMSCs) are attractive for the bone tissue engineering due to their convenient harvesting, easy transfection with exogenous genes and multi-lineage differentiating potential [19,20].”
BackgroundSelf-assembled collagen–human mesenchymal stem cell microspheres for regenerative medicine
Chan, B. P., Hui, T. Y., Yeung, C. W., Li, J., Mo, I., & Chan, G. C. F. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.07.041 · Cited by 174
“Differentiation assays for chondrogenesis, oesteogenesis and adipogenesis were performed [6,29,30] to investigate whether hMSCs obtained from the 3D microspheres still retained the multi-potent differentiating potential.”
BackgroundMethodInfluentialBaksh, D., Boland, G. M., & Tuan, R. S. (2007) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21097 · Cited by 174
“Although MSCs have been isolated and cultured successfully and their phenotypic and functional propertieswell characterized [Caplan, 1991; Bruder et al., 1997; Pittenger et al., 1999], the mechanisms regulating MSC developmental potential remain to be elucidated.”
BackgroundStem Cells in Dental Pulp of Deciduous Teeth
Kerkis, I., & Caplan, A. I. (2012) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2011.0327 · Cited by 174
Kanki-Horimoto, S., Horimoto, H., Mieno, S., Kishida, K., Watanabe, F., Furuya, E., & Katsumata, T. (2006) · Circulation · doi:10.1161/circulationaha.105.001487 · Cited by 174
Reciprocal Roles of Msx2 in Regulation of Osteoblast and Adipocyte Differentiation
Ichida, F., Nishimura, R., Hata, K., Matsubara, T., Ikeda, F., Hisada, K., Yatani, H., Cao, X., Komori, T., Yamaguchi, A., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m403621200 · Cited by 173
Chitosan for Gene Delivery and Orthopedic Tissue Engineering Applications
Raftery, R., O'Brien, F., & Cryan, S.-A. (2013) · Molecules · doi:10.3390/molecules18055611 · Cited by 173
“down the chondrogenic lineage and therefore may provide an alternative to chondrocytes [179].”
BackgroundKang, B.-J., Ryu, H.-H., Park, S. S., Koyama, Y., Kikuchi, M., Woo, H.-M., Kim, W. H., & Kweon, O.-K. (2012) · Journal of Veterinary Science · doi:10.4142/jvs.2012.13.3.299 · Cited by 173
“MSCs have received extensive attention in the fields of tissue engineering and regenerative medicine because they can be easily harvested in a minimally invasive manner, propagate in vitro, and possess valuable properties such as multipotency, paracrine activities, and immune modulation abilities [3,18,30].”
BackgroundMigration of mesenchymal stem cells to heart allografts during chronic rejection
Wu, G. D., Nolta, J. A., Jin, Y.-S., Barr, M. L., Yu, H., Starnes, V. A., & Cramer, D. V. (2003) · Transplantation · doi:10.1097/01.tp.0000048488.35010.95 · Cited by 173
“The differentiation potential of MSC is determined by their developmental stages in which, for example, uncommitted MSCs are multipotent progenitors whereas committed MSCs are lineage-directed (11, 12).”
BackgroundThe tissue origin effect of extracellular vesicles on cartilage and bone regeneration
Li, Q., Yu, H., Sun, M., Yang, P., Hu, X., Ao, Y., & Cheng, J. (2021) · Acta Biomaterialia · doi:10.1016/j.actbio.2021.02.039 · Cited by 172
Isolation of multipotent stem cells from mouse adipose tissue
Yamamoto, N., Akamatsu, H., Hasegawa, S., Yamada, T., Nakata, S., Ohkuma, M., Miyachi, E.-I., Marunouchi, T., & Matsunaga, K. (2007) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2007.05.015 · Cited by 172
“On the other hand, cells derived from bone marrow, adipose tissue or other tissues have attracted attention nowadays as clinically applicable sources of autografting cells, because these cells can differentiate into various types of cells, including smooth muscle cells, endothelial cells and neuronal cells [2—7].”
BackgroundMesenchymal Stem Cells in Cancer: Tumor-Associated Fibroblasts and Cell-Based Delivery Vehicles
Hall, B., Dembinski, J., Sasser, A., Studeny, M., Andreeff, M., & Marini, F. (2007) · International Journal of Hematology · doi:10.1532/ijh97.06230 · Cited by 171
Ouyang, H. W., Goh, J. C. H., & Lee, E. H. (2004) · The American Journal of Sports Medicine · doi:10.1177/0095399703258682 · Cited by 171
“the progenitors of various structural and connective tissues, including bone, cartilage, fat, tendon, and muscle.(17,18) The cells have been studied extensively for bone(4) and cartilage(8) regeneration.”
BackgroundBlau, O., Hofmann, W.-K., Baldus, C. D., Thiel, G., Serbent, V., Schümann, E., Thiel, E., & Blau, I. W. (2007) · Experimental Hematology · doi:10.1016/j.exphem.2006.10.012 · Cited by 171
Li, H., Li, T., Wang, S., Wei, J., Fan, J., Li, J., Han, Q., Liao, L., Shao, C., & Zhao, R. C. (2013) · Stem Cell Research · doi:10.1016/j.scr.2012.11.007 · Cited by 171
Dahl, J.-A., Duggal, S., Coulston, N., Millar, D., Melki, J., Shahdadfar, A., Brinchmann, J. E., & Collas, P. (2008) · The International Journal of Developmental Biology · doi:10.1387/ijdb.082663jd · Cited by 171
“Bone marrow MSCs (BMMSCs) can differentiate into mesodermal lineages (Pittenger et al., 1999) and a small subpopulation seems to exhibit more extensive differentiation ability (Jiang et al., 2002).”
BackgroundNanofiber-based delivery of bioactive agents and stem cells to bone sites
Zhang, Z., Hu, J., & Ma, P. X. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.04.008 · Cited by 170
Ishige, I., Nagamura-Inoue, T., Honda, M. J., Harnprasopwat, R., Kido, M., Sugimoto, M., Nakauchi, H., & Tojo, A. (2009) · International Journal of Hematology · doi:10.1007/s12185-009-0377-3 · Cited by 170
“Mesenchymal stem cells (MSC) possess the capacity for self-renewal and differentiation into several types of cells, including osteocytes, adipocytes, chondrocytes [1], myocytes [2], cardiomyocytes [3], and neurons [4].”
BackgroundOsteogenesis and Bone-Marrow-Derived Cells
Long, M. W. (2001) · Blood Cells, Molecules, and Diseases · doi:10.1006/bcmd.2001.0431 · Cited by 170
Herrmann, J. L., Wang, Y., Abarbanell, A. M., Weil, B. R., Tan, J., & Meldrum, D. R. (2010) · Shock · doi:10.1097/shk.0b013e3181b7d137 · Cited by 170
Mesenchymal stem cell-educated macrophages
Eggenhofer, E., & Hoogduijn, M. J. (2012) · Transplantation Research · doi:10.1186/2047-1440-1-12 · Cited by 169
“Introduction Mesenchymal stem cells (MSC) are stromal cells with potent regenerative and immunomodulatory properties [1,2].”
BackgroundEndres, M., Hutmacher, D. W., Salgado, A. J., Kaps, C., Ringe, J., Reis, R. L., Sittinger, M., Brandwood, A., & Schantz, J. T. (2003) · Tissue Engineering · doi:10.1089/107632703768247386 · Cited by 169
“16,18 We demonstrated that for this experiment isolated mesenchymal progenitors derived from juvenile bone marrow have the potential to undergo multiple differentiation pathways.”
Beggs, K. J., Lyubimov, A., Borneman, J. N., Bartholomew, A., Moseley, A., Dodds, R., Archambault, M. P., Smith, A. K., & Mcintosh, K. R. (2006) · Cell Transplantation · doi:10.3727/000000006783981503 · Cited by 169
Role of mesenchymal stem cells in hematopoietic stem cell transplantation
Devine, S. M., & Hoffman, R. (2000) · Current Opinion in Hematology · doi:10.1097/00062752-200011000-00007 · Cited by 169
Activity of mesenchymal stem cells in therapies for chronic skin wound healing
Nuschke, A. (2014) · Organogenesis · doi:10.4161/org.27405 · Cited by 169
Mesenchymal stem cell secretome and regenerative therapy after cancer
Zimmerlin, L., Park, T. S., Zambidis, E. T., Donnenberg, V. S., & Donnenberg, A. D. (2013) · Biochimie · doi:10.1016/j.biochi.2013.05.010 · Cited by 168
“The attractiveness of MSC for cell-based regenerative therapies relies not only on their capacity to differentiate into multiple mesenchymal lineages [10], but also on the delivery of various paracrine signals responsible for chemoattractant, immunomodulatory, angiogenic, anti-apoptotic, anti-scarring, and pro-surviva…”
BackgroundYoo, S.-W., Kim, S.-S., Lee, S.-Y., Lee, H.-S., Kim, H.-S., Lee, Y.-D., & Suh-Kim, H. (2008) · Experimental and Molecular Medicine · doi:10.3858/emm.2008.40.4.387 · Cited by 168
“To determine the potential for MSCs to differentiate into mesodermal lineage such as chondrocytes, osteocytes and adipocytes, differentiation was induced according to the procedures described by Pittenger et al. (1999).”
BackgroundMethodInfluentialGreen, D. E., & Rubin, C. T. (2014) · Bone · doi:10.1016/j.bone.2014.02.018 · Cited by 168
“Mesenchymal stem cells are multipotent cells that have the potential to differentiate into numerous lineages, including adipocytes, osteoblasts, and chondrocytes [29].”
BackgroundJäger, M., Wild, A., Westhoff, B., & Krauspe, R. (2004) · Journal of Orthopaedic Science · doi:10.1007/s00776-004-0770-y · Cited by 168
Obesity-mediated inflammatory microenvironment stimulates osteoclastogenesis and bone loss in mice
Halade, G. V., El Jamali, A., Williams, P. J., Fajardo, R. J., & Fernandes, G. (2011) · Experimental Gerontology · doi:10.1016/j.exger.2010.09.014 · Cited by 168
“Activation of PPARγ stimulates adipogenesis and inhibits osteogenesis (David et al., 2007), as they share a common progenitor, i.e., MSC in the BM (Pittenger et al., 1999).”
Schurgers, E., Kelchtermans, H., Mitera, T., Geboes, L., & Matthys, P. (2010) · Arthritis Research & Therapy · doi:10.1186/ar2939 · Cited by 168
“Bone marrow-derived mesenchymal stem cells (MSCs) are multipotent progenitor cells that can differentiate into cells of the mesenchymal lineage like bone, fat, and cartilage [1].”
BackgroundMajore, I., Moretti, P., Stahl, F., Hass, R., & Kasper, C. (2011) · Stem Cell Reviews and Reports · doi:10.1007/s12015-010-9165-y · Cited by 167
“These somatic stem cells (SC) on the one hand possess the capability for extensive selfrenewal, on the other hand the potential to differentiate into various highly specialized cell types of mesodermal [2, 3] and even ectodermal [4, 5] or endodemal origin [6, 7].”
BackgroundChinnadurai, R., Copland, I. B., Garcia, M. A., Petersen, C. T., Lewis, C. N., Waller, E. K., Kirk, A. D., & Galipeau, J. (2016) · Stem Cells · doi:10.1002/stem.2415 · Cited by 167
Ogura, F., Wakao, S., Kuroda, Y., Tsuchiyama, K., Bagheri, M., Heneidi, S., Chazenbalk, G., Aiba, S., & Dezawa, M. (2014) · Stem Cells and Development · doi:10.1089/scd.2013.0473 · Cited by 166
“SSEA-3( + )-adipose-Muse cells (labeled with FITC) were analyzed by flow cytometry for the expression of cell surface antigens CD29 [labeled with phy-coerythrin (PE)], CD90 (PE), CD105 (Pacific Blue), CD34 (PE), and CD146 (PE) (Becton Dickinson).”
HAN, H., HU, J., YAN, Q., ZHU, J., ZHU, Z., CHEN, Y., SUN, J., & ZHANG, R. (2016) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4726 · Cited by 166
“Due to their numerous advantages, including abundant sources, high levels of activity, immune privilege, high proliferation and differentiation potential and nutrient secretion, the use of MSCs in cell therapies are considered among the most promising approaches to repair damaged cardiac tissue in IHD, including myoca…”
BackgroundKilian, K. A., & Mrksich, M. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201108746 · Cited by 166
Yang, X., Tare, R. S., Partridge, K. A., Roach, H. I., Clarke, N. M., Howdle, S. M., Shakesheff, K. M., & Oreffo, R. O. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.1.47 · Cited by 166
Grossman, S. R., Zhang, X., Wang, L., Engreitz, J., Melnikov, A., Rogov, P., Tewhey, R., Isakova, A., Deplancke, B., Bernstein, B. E., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1621150114 · Cited by 165
In vitro differentiation of human mesenchymal stem cells to epithelial lineage
Păunescu, V., Deak, E., Herman, D., Siska, I. R., T˘anasie, G., Bunu, C., Anghel, S., Tatu, C. A., Oprea, T. I., Henschler, R., et al. (2007) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00041.x · Cited by 165
Regulating the stemness of mesenchymal stem cells by tuning micropattern features
Wang, X., Nakamoto, T., Dulińska-Molak, I., Kawazoe, N., & Chen, G. (2016) · Journal of Materials Chemistry B · doi:10.1039/c5tb02215k · Cited by 165
Embryonic stem cells in drug discovery
McNeish, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1281 · Cited by 165
“Although human, pluripotent adult stem-cell lines are being identified from bone marro”
BackgroundBiological and biophysical principles in extracorporal bone tissue engineering
Meyer, U., Joos, U., & Wiesmann, H. P. (2004) · International Journal of Oral and Maxillofacial Surgery · doi:10.1016/s0901-5027(03)00199-1 · Cited by 165
Mesenchymal progenitor cells localize within hematopoietic sites throughout ontogeny
Mendes, S. C., Robin, C., & Dzierzak, E. (2005) · Development · doi:10.1242/dev.01615 · Cited by 165
“2A), a widely recognized marker of osteogenic activity (D’Ippolito et al., 1999; Oyajobi et al., 1999; Pittenger et al., 1999), and the cultures contained mRNA for bone cell specific genes such as osteopontin and osteocalcin, none of which was expressed at detectable levels in freshly isolated AGM…”
BackgroundResultInfluentialTargeted Delivery of CX3CL1 to Multiple Lung Tumors by Mesenchymal Stem Cells
Xin, H., Kanehira, M., Mizuguchi, H., Hayakawa, T., Kikuchi, T., Nukiwa, T., & Saijo, Y. (2007) · STEM CELLS · doi:10.1634/stemcells.2006-0461 · Cited by 164
Bosch, P., Pratt, S. L., & Stice, S. L. (2006) · Biology of Reproduction · doi:10.1095/biolreprod.105.045138 · Cited by 164
Human Mesenchymal Stem Cells Maintain Transgene Expression during Expansion and Differentiation
Lee, K., Majumdar, M. K., Buyaner, D., Hendricks, J. K., Pittenger, M. F., & Mosca, J. D. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0327 · Cited by 164
Self-citationHuman Adipose Stem Cells: From Bench to Bedside
De Francesco, F., Ricci, G., D'Andrea, F., Nicoletti, G. F., & Ferraro, G. A. (2015) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2014.0608 · Cited by 163
Bonvillain, R. W., Danchuk, S., Sullivan, D. E., Betancourt, A. M., Semon, J. A., Eagle, M. E., Mayeux, J. P., Gregory, A. N., Wang, G., Townley, I. K., et al. (2012) · Tissue Engineering Part A · doi:10.1089/ten.tea.2011.0594 · Cited by 163
Sun, L., Li, D., Song, K., Wei, J., Yao, S., Li, Z., Su, X., Ju, X., Chao, L., Deng, X., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-02786-x · Cited by 163
CD271 as a marker to identify mesenchymal stem cells from diverse sources before culture
Álvarez-Viejo, M. (2015) · World Journal of Stem Cells · doi:10.4252/wjsc.v7.i2.470 · Cited by 163
Mesenchymal Stem Cell Mechanics from the Attached to the Suspended State
Maloney, J. M., Nikova, D., Lautenschläger, F., Clarke, E., Langer, R., Guck, J., & Van Vliet, K. J. (2010) · Biophysical Journal · doi:10.1016/j.bpj.2010.08.052 · Cited by 163
“F 1⁄4 4Ed ffiffiffi R p =3 1 n(2) ; (1)”
BackgroundInfluentialTomita, K., Madura, T., Sakai, Y., Yano, K., Terenghi, G., & Hosokawa, K. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2012.12.066 · Cited by 163
Unraveling the Mesenchymal Stromal Cells' Paracrine Immunomodulatory Effects
Fontaine, M. J., Shih, H., Schäfer, R., & Pittenger, M. F. (2016) · Transfusion Medicine Reviews · doi:10.1016/j.tmrv.2015.11.004 · Cited by 162
“Mesenchymal stem cells (MSCs), also known as multipotent mesenchymal stromal cells, are a heterogeneous population of fibroblast-like and plastic-adherent cells with self-renewal and differentiation potential to lineages of mesenchymal tissues including bone, cartilage, and fat [1].”
BackgroundSelf-citationJeon, E. S., Moon, H. J., Lee, M. J., Song, H. Y., Kim, Y. M., Bae, Y. C., Jung, J. S., & Kim, J. H. (2006) · Journal of Cell Science · doi:10.1242/jcs.03281 · Cited by 162
Costela-Ruiz, V. J., Melguizo-Rodríguez, L., Bellotti, C., Illescas-Montes, R., Stanco, D., Arciola, C. R., & Lucarelli, E. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116356 · Cited by 162
“This led Caplan and Correa [111] to coin the expression “medicinal stem cells”, precisely to indicate that mesenchymal stem cells are an in vivo site-regulated “drugstore” of growth factors, cytokines, and other pro-regenerative, immuno-modulatory, anti-inflammatory molecules.”
BackgroundInfluentialCarvalho, A. B., Quintanilha, L. F., Dias, J. V., Paredes, B. D., Mannheimer, E. G., Carvalho, F. G., Asensi, K. D., Gutfilen, B., Fonseca, L. M. B., Resende, C. M. C., et al. (2008) · Stem Cells · doi:10.1634/stemcells.2007-0941 · Cited by 162
Zhidu, S., Ying, T., Rui, J., & Chao, Z. (2024) · Stem Cell Research & Therapy · doi:10.1186/s13287-024-03885-z · Cited by 162
“Pittenger et al. detected this characteristic in MSCs through their differentiation into chondrogenic, adipogenic, or osteogenic cells within 1 to 3 weeks [14].”
BackgroundAutophagy: a potential key contributor to the therapeutic action of mesenchymal stem cells
Ceccariglia, S., Cargnoni, A., Silini, A. R., & Parolini, O. (2020) · Autophagy · doi:10.1080/15548627.2019.1630223 · Cited by 161
“MSCs, defined as an adherent fibroblast-like population with the ability to self-renew [44], were first identified in human bone marrow [45] and have been the most widely studied MSC population.”
BackgroundJeon, E. S., Moon, H. J., Lee, M. J., Song, H. Y., Kim, Y. M., Cho, M., Suh, D.-S., Yoon, M.-S., Chang, C. L., Jung, J. S., et al. (2008) · Stem Cells · doi:10.1634/stemcells.2007-0742 · Cited by 161
Poggi, A., Prevosto, C., Massaro, A.-M., Negrini, S., Urbani, S., Pierri, I., Saccardi, R., Gobbi, M., & Zocchi, M. R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.10.6352 · Cited by 161
Inflammation, mesenchymal stem cells and bone regeneration
Liu, H., Li, D., Zhang, Y., & Li, M. (2018) · Histochemistry and Cell Biology · doi:10.1007/s00418-018-1643-3 · Cited by 160
Roobrouck, V. D., Clavel, C., Jacobs, S. A., Ulloa-Montoya, F., Crippa, S., Sohni, A., Roberts, S. J., Luyten, F. P., Van Gool, S. W., Sampaolesi, M., et al. (2011) · Stem Cells · doi:10.1002/stem.633 · Cited by 160
Guilak, F., Estes, B. T., Diekman, B. O., Moutos, F. T., & Gimble, J. M. (2010) · Clinical Orthopaedics & Related Research · doi:10.1007/s11999-010-1410-9 · Cited by 160
“Depending on their differentiation potential and site of origin, these cells have been described using various terms, such as MSCs, multipotent adult progenitor cells, marrow stromal cells, or mesenchymal progenitors [13, 15, 17, 44, 68, 69, 72–74, 80, 85].”
BackgroundEffects of Ectopic Nanog and Oct4 Overexpression on Mesenchymal Stem Cells
Liu, T. M., Wu, Y. N., Guo, X. M., Hui, J. H. P., Lee, E. H., & Lim, B. (2009) · Stem Cells and Development · doi:10.1089/scd.2008.0335 · Cited by 160
“Their most immediate use is in the orthopedic context because of the clear demonstration of their ability to differentiate into bone and cartilage [1,7].”
BackgroundFu, X., Fang, L., Li, X., Cheng, B., & Sheng, Z. (2006) · Wound Repair and Regeneration · doi:10.1111/j.1743-6109.2006.00128.x · Cited by 159
“Thus, the differentiation of MSCs to endothelial cells, sebaceous duct and epidermal cells suggests that these transplanted cells respond to signals from the injured skin that promote their migration, proliferation and differentiation within the wound bed.(1,4,26) The extracellular factor(s) of culture medium, locally…”
BackgroundInduced periosteum a complex cellular scaffold for the treatment of large bone defects
Cuthbert, R. J., Churchman, S. M., Tan, H. B., McGonagle, D., Jones, E., & Giannoudis, P. V. (2013) · Bone · doi:10.1016/j.bone.2013.08.009 · Cited by 159
Chondrogenic Differentiation of Human Embryonic Stem Cells: The Effect of the Micro-Environment
Vats, A., Bielby, R. C., Tolley, N., Dickinson, S. C., Boccaccini, A. R., Hollander, A. P., Bishop, A. E., & Polak, J. M. (2006) · Tissue Engineering · doi:10.1089/ten.2006.12.1687 · Cited by 159
Zhou, L., Chen, X., Liu, T., Gong, Y., Chen, S., Pan, G., Cui, W., Luo, Z., Pei, M., Yang, H., et al. (2015) · Journal of Pineal Research · doi:10.1111/jpi.12250 · Cited by 158
Lee, J.-H., & Kemp, D. M. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.01.038 · Cited by 158
Gap junctions and hemichannels in signal transmission, function and development of bone
Batra, N., Kar, R., & Jiang, J. X. (2012) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2011.09.018 · Cited by 158
“can readily differentiate into adipose tissue, tendon, cartilage and bone [188].”
BackgroundSalinas, C. N., Cole, B. B., Kasko, A. M., & Anseth, K. S. (2007) · Tissue Engineering · doi:10.1089/ten.2006.0126 · Cited by 158
Garreta, E., Genové, E., Borrós, & Semino, C. E. (2006) · Tissue Engineering · doi:10.1089/ten.2006.12.2215 · Cited by 158
“16,38,39 The medium was changed every 2 days.”
Lim, J. Y., Park, S. I., Oh, J. H., Kim, S. M., Jeong, C. H., Jun, J. A., Lee, K., Oh, W., Lee, J., & Jeun, S. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21669 · Cited by 158
“Unexpectedly, MSCs have also been reported to possess the potential to differentiate into both endodermal and ectodermal tissues (Pittenger et al., 1999; Yang et al., 2004).”
BackgroundKronsteiner, B., Wolbank, S., Peterbauer, A., Hackl, C., Redl, H., van Griensven, M., & Gabriel, C. (2011) · Stem Cells and Development · doi:10.1089/scd.2011.0031 · Cited by 158
Chen, C.-W., Montelatici, E., Crisan, M., Corselli, M., Huard, J., Lazzari, L., & Péault, B. (2009) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.10.014 · Cited by 158
From streaming‐potentials to shear stress: 25 years of bone cell mechanotransduction
Riddle, R. C., & Donahue, H. J. (2009) · Journal of Orthopaedic Research · doi:10.1002/jor.20723 · Cited by 157
Stem cells and tissue engineering: past, present, and future
POLAK, J. M., & BISHOP, A. E. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1346.001 · Cited by 155
Meng, J., Ma, X., Wang, N., Jia, M., Bi, L., Wang, Y., Li, M., Zhang, H., Xue, X., Hou, Z., et al. (2016) · Stem Cell Reports · doi:10.1016/j.stemcr.2016.02.002 · Cited by 155
Brandau, S., Jakob, M., Hemeda, H., Bruderek, K., Janeschik, S., Bootz, F., & Lang, S. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.0410207 · Cited by 155
“In common protocols, MSCs are isolated from diverse tissues by a plastic adherence selection step and subsequent culture expansion [2, 5, 20].”
Background3D bioprinting: improving in vitro models of metastasis with heterogeneous tumor microenvironments
Albritton, J. L., & Miller, J. S. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.025049 · Cited by 154
“TGF-β 1 and BMP-2 have both been previously reported to promote osteogenic and chondrogenic differentiation in hMSCs (Dickhut et al., 2010; Pittenger, 1999).”
Espagnolle, N., Guilloton, F., Deschaseaux, F., Gadelorge, M., Sensébé, L., & Bourin, P. (2014) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12168 · Cited by 154
Microencapsulated human mesenchymal stem cells decrease liver fibrosis in mice
Meier, R. P. H., Mahou, R., Morel, P., Meyer, J., Montanari, E., Muller, Y. D., Christofilopoulos, P., Wandrey, C., Gonelle-Gispert, C., & Bühler, L. H. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2014.10.030 · Cited by 153
Neuss, S., Blomenkamp, I., Stainforth, R., Boltersdorf, D., Jansen, M., Butz, N., Perez-Bouza, A., & Knüchel, R. (2009) · Biomaterials · doi:10.1016/j.biomaterials.2008.12.027 · Cited by 151
“For adipogenic and osteogenic differentiation, cells were treated according to Pittenger and coworkers [21] as previously described [22].”
MethodGenetic Engineering of Mesenchymal Stem Cells and Its Application in Human Disease Therapy
Hodgkinson, C. P., Gomez, J. A., Mirotsou, M., & Dzau, V. J. (2010) · Human Gene Therapy · doi:10.1089/hum.2010.165 · Cited by 150
“MSCs offer several benefits that make them ideal therapeutic agents for regenerative medicine (Pittenger et al., 1999; Boyle et al., 2010; Griffin et al., 2010; Salem and Thiemermann, 2010).”
Garayoa, M., Garcia, J. L., Santamaria, C., Garcia-Gomez, A., Blanco, J. F., Pandiella, A., Hernández, J. M., Sanchez-Guijo, F. M., del Cañizo, M.-C., Gutiérrez, N. C., et al. (2009) · Leukemia · doi:10.1038/leu.2009.65 · Cited by 148
Seo, S. H., Kim, K. S., Park, S. H., Suh, Y. S., Kim, S. J., Jeun, S.-S., & Sung, Y. C. (2011) · Gene Therapy · doi:10.1038/gt.2010.170 · Cited by 148
Yin, Z., Chen, X., Zhu, T., Hu, J.-J., Song, H.-X., Shen, W.-L., Jiang, L.-Y., Heng, B. C., Ji, J.-F., & Ouyang, H.-W. (2013) · Acta Biomaterialia · doi:10.1016/j.actbio.2013.07.022 · Cited by 148
Metadata
- Authors
- Pittenger, M. F., Mackay, A. M., Beck, S. C., Jaiswal, R. K., Douglas, R., Mosca, J. D., Moorman, M. A., Simonetti, D. W., Craig, S., & Marshak, D. R.
- Affiliations
- Osiris Therapeutics (United States) (US)
- Johns Hopkins University (US)
- Corresponding author
- Pittenger, Mark F.
- ORCID
- Pittenger, Mark F.
- Venue
- Science
- Published
- 1999-04-02
- Volume
- 284
- Issue
- 5411
- Pages
- 143-147
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2159999899
- Cited by
- 21,052
- References
- 37
- Citations by year
- 2026: 265 · 2025: 373 · 2024: 497 · 2023: 541 · 2022: 604 · 2021: 778 · 2020: 856 · 2019: 766 · 2018: 884 · 2017: 962 · 2016: 1083 · 2015: 1145 · 2014: 1255 · 2013: 1344 · 2012: 1384
- FWCI
- 138.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
- Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Keywords
- mesenchymal stem cells, multilineage differentiation, multipotency, bone marrow, adipogenesis, chondrogenic differentiation, osteogenic differentiation, stem cell isolation, colony expansion, stem cell phenotype
- MeSH terms
- Adult, Bone Marrow Cells, Cell Differentiation, Cell Division, Cell Separation, Cells, Cultured, Fibroblasts, Flow Cytometry, Humans, Mesoderm, Middle Aged, Osteocytes, Phenotype, Stem Cells, Apoptosis, Adipocytes, Cell Lineage, Chondrocytes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.